Wordt geladen...
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
Background: Breast cancer patients with residual disease after neoadjuvant chemotherapy (NAC) have increased recurrence risk. Molecular characterization, knowledge of NAC response, and simultaneous generation of patient-derived xenografts (PDXs) may accelerate drug development. However, the feasibil...
Bewaard in:
| Gepubliceerd in: | J Natl Cancer Inst |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5408989/ https://ncbi.nlm.nih.gov/pubmed/28376176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw306 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|